Home
Article
Licensed
Unlicensed Requires Authentication

Published/Copyright: May 8, 2009
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Clinical Chemistry and Laboratory Medicine (CCLM) Volume 47 Issue S1

Abstract

Cardiovascular diseases

Clinical toxicology

How to define and determine reference intervals and decision limits in laboratory medicine

Biobanking concepts – need for an integrated European solution

Vitamin D metabolites in cancer, immunological and cardiovascular diseases

From stem cells to cardiovascular therapy

Screening and identifying small to large molecules in clinical chemistry by mass spectrometry

Quality management in Europe – implementation of ISO-15189

Diabetes mellitus, atherosclerosis, renal failure – ‘post translational pathologies’

Pediatric reference ranges

Standardization activities in endocrinology

Proteomics and human diseases

Translational research: re-engineering the laboratory medicine enterprise

Pharmacogenetics in laboratory medicine: from bench to bedside

Update on cardiovascular markers

Frontiers in molecular haemato-oncology

Genomic instability syndrome

Evidence-based evaluation of new specialized tests and their cost-effectiveness

Obesities, diabetes type II and metabolic syndrome; new clinical and diagnostic ways

Modern concepts in external quality assurance

New biological markers in neurological disorders: presence & future

Diagnosis and management of bone and joint diseases

Biology and diagnostics of renal function

Autoimmune diseases

Laboratory performance and patient safety

Frontiers in therapeutic drug monitoring

POCT: models for delivery in hospitals, GP practice and home. Ensure quality and improved patient outcome

Genetic disorders of body fluid homeostasis

Guidelines for pharmacogenetics/an IFCC integrated project

Biostatistics

Published Online: 2009-05-08
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Committees
  2. Committees
  3. Plenary Lecture Abstracts
  5. EUSPM Symposium Abstracts
  7. Symposium Abstracts
  9. Industry Sponsored Workshop Abstracts
  11. Poster Abstracts
  12. Ageing
  13. Ageing
  14. Allergy
  15. Allergy
  16. Autoimmune diseases
  17. Autoimmune diseases
  18. Blood banking and haemovigilance
  19. Blood banking and haemovigilance
  20. Bone disease and vitamin D
  21. Bone disease and vitamin D
  22. Coronary artery disease/ischemic damage
  23. Coronary artery disease/ischemic damage
  24. Cardiovascular disease: Heart failure/hypertension
  25. Cardiovascular disease: Heart failure/hypertension
  26. Cancer/tumour markers
  27. Cancer/tumour markers
  28. Clinical importance of laboratory testing
  29. Clinical importance of laboratory testing
  30. Critical care testing
  31. Critical care testing
  32. Diabetes mellitus
  33. Diabetes mellitus
  34. Fertility
  35. Fertility
  36. Genetics
  37. Genetics
  38. Haematology
  39. Haematology
  40. Haemostasis
  41. Haemostasis
  42. Immunology
  43. Immunology
  44. Immunoassays
  45. Immunoassays
  46. Infectious diseases
  47. Infectious diseases
  48. Information technology
  49. Information technology
  50. Inherited and acquired metabolic diseases
  51. Inherited and acquired metabolic diseases
  52. Iron metabolism/haemochromatosis
  53. Iron metabolism/haemochromatosis
  54. Kidney disease
  55. Kidney disease
  56. Lipids and lipoproteins
  57. Lipids and lipoproteins
  58. Liver and gastrointestinal diseases
  59. Liver and gastrointestinal diseases
  60. Mass spectrometry
  61. Mass spectrometry
  62. Metabolic syndrome(s)
  63. Metabolic syndrome(s)
  64. Metabolomics
  65. Metabolomics
  66. Molecular diagnostics
  67. Molecular diagnostics
  68. Neonatology
  69. Neonatology
  70. Neurodegenerative diseases
  71. Neurodegenerative diseases
  72. Nutrition
  73. Nutrition
  74. Paediatric clinical chemistry
  75. Paediatric clinical chemistry
  76. Pharmacogenetics/pharmacogenomics
  77. Pharmacogenetics/pharmacogenomics
  78. Point of care testing
  79. Point of care testing
  80. Proteins and proteomics
  81. Proteins and proteomics
  82. Quality assessment
  83. Quality assessment
  84. Reproductive endocrinology
  85. Reproductive endocrinology
  86. Rheumatology
  87. Rheumatology
  88. Stroke
  89. Stroke
  90. Technology, instrumentation and methods
  91. Technology, instrumentation and methods
  92. Thyroid function
  93. Thyroid function
  94. Traceability and standardisation
  95. Traceability and standardisation
  96. Miscellaneous
  97. Miscellaneous
  98. Author Index
  99. Author Index
https://doi.org/10.1515/CCLM.2009.383

Articles in the same Issue

  1. Committees
  2. Committees
  3. Plenary Lecture Abstracts
  5. EUSPM Symposium Abstracts
  7. Symposium Abstracts
  9. Industry Sponsored Workshop Abstracts
  11. Poster Abstracts
  12. Ageing
  13. Ageing
  14. Allergy
  15. Allergy
  16. Autoimmune diseases
  17. Autoimmune diseases
  18. Blood banking and haemovigilance
  19. Blood banking and haemovigilance
  20. Bone disease and vitamin D
  21. Bone disease and vitamin D
  22. Coronary artery disease/ischemic damage
  23. Coronary artery disease/ischemic damage
  24. Cardiovascular disease: Heart failure/hypertension
  25. Cardiovascular disease: Heart failure/hypertension
  26. Cancer/tumour markers
  27. Cancer/tumour markers
  28. Clinical importance of laboratory testing
  29. Clinical importance of laboratory testing
  30. Critical care testing
  31. Critical care testing
  32. Diabetes mellitus
  33. Diabetes mellitus
  34. Fertility
  35. Fertility
  36. Genetics
  37. Genetics
  38. Haematology
  39. Haematology
  40. Haemostasis
  41. Haemostasis
  42. Immunology
  43. Immunology
  44. Immunoassays
  45. Immunoassays
  46. Infectious diseases
  47. Infectious diseases
  48. Information technology
  49. Information technology
  50. Inherited and acquired metabolic diseases
  51. Inherited and acquired metabolic diseases
  52. Iron metabolism/haemochromatosis
  53. Iron metabolism/haemochromatosis
  54. Kidney disease
  55. Kidney disease
  56. Lipids and lipoproteins
  57. Lipids and lipoproteins
  58. Liver and gastrointestinal diseases
  59. Liver and gastrointestinal diseases
  60. Mass spectrometry
  61. Mass spectrometry
  62. Metabolic syndrome(s)
  63. Metabolic syndrome(s)
  64. Metabolomics
  65. Metabolomics
  66. Molecular diagnostics
  67. Molecular diagnostics
  68. Neonatology
  69. Neonatology
  70. Neurodegenerative diseases
  71. Neurodegenerative diseases
  72. Nutrition
  73. Nutrition
  74. Paediatric clinical chemistry
  75. Paediatric clinical chemistry
  76. Pharmacogenetics/pharmacogenomics
  77. Pharmacogenetics/pharmacogenomics
  78. Point of care testing
  79. Point of care testing
  80. Proteins and proteomics
  81. Proteins and proteomics
  82. Quality assessment
  83. Quality assessment
  84. Reproductive endocrinology
  85. Reproductive endocrinology
  86. Rheumatology
  87. Rheumatology
  88. Stroke
  89. Stroke
  90. Technology, instrumentation and methods
  91. Technology, instrumentation and methods
  92. Thyroid function
  93. Thyroid function
  94. Traceability and standardisation
  95. Traceability and standardisation
  96. Miscellaneous
  97. Miscellaneous
  98. Author Index
  99. Author Index
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.383/html
Scroll to top button